Innovative Delivery System for Methylphenidate

Jorna PM is a methylphenidate medication with a delayed activation extended release delivery system, offering improved effectiveness compared to traditional medication. This innovative system addresses the issue of slow activation time in existing medications, particularly beneficial for families and adults with ADHD. While children experience improved focus and attention after the initial activation period, adults too may benefit from delayed activation due to their delayed diurnal rhythm. This delayed diurnal rhythm results in adults with ADHD being most alert during afternoon and nighttime hours, posing challenges in a traditional work schedule that starts early in the day.